EXPRESS: Pulmonary vasodilators: beyond the bounds of PAH therapy in COVID-19
2020
Pulmonary arterial hypertension (PAH) and novel coronavirus (SARS-CoV-2) disease COVID-19 are characterized by extensive endothelial dysfunction and inflammation leading to vascular remodeling and ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
65
References
3
Citations
NaN
KQI